Skip to main content
OpenTrials
Completed

NCT Number: NCT01801202

Clinical Evaluation of LightSheer Duet 805nm HS Handpiece

* The study will re-confirm that the LightSheer Duet HS 805 nm handpiece is safe for removal of unwanted hair, and will result in hair removal and permanent hair count reduction. * Twenty (20)subjects, Fitzpatrick Skin Type I-IV will be included in a single site. * Each subject will receive five treatments at four to six week intervals and return for follow-up visits at three and six months after the last treatment for evaluation of the treated areas.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Laser & Skin Surgery Medical Group Inc

Sacramento, California, 95816, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Able to read, understand and provide written Informed Consent;
  • Healthy adult, male or female, 18 years of age or older with skin type I-IV;
  • Having a suitable treatment area for hair removal;
  • Able and willing to comply with the treatment/follow-up schedule and requirements;
  • Women of child-bearing potential (women who have not had a hysterectomy, bilateral oophorectomy or are not postmenopausal) are required to be using a reliable method of birth control at least three months prior to enrollment and throughout the course of the study.

Exclusion criteria

  • Pregnant, expectation of pregnancy, postpartum or nursing (<6 months);
  • Hormonal disorders that may affect hair growth;
  • Immunosuppressive diseases, including AIDS and HIV infection, or use of immunosuppressive medications;
  • Livedo reticularis;
  • Uncontrolled systemic diseases such as diabetes;
  • Active infections in the treated area;
  • Dysplastic nevi;
  • Significant concurrent skin conditions or any inflammatory skin conditions;
  • Active cold sores, open lacerations or abrasions;
  • Chronic or cutaneous viral, fungal, or bacterial diseases;
  • Current cancer;
  • History of skin cancer or pre-cancerous lesions at the treatment areas;
  • Use of Accutane™ (Isotretinoin) within the past six month;
  • Keloid formation in the treatment area;
  • Tattoos in the treatment area;
  • Bleeding coagulopathies or use of anticoagulants;
  • Auto-immune disorders;
  • Erythema ab igne, when identified treatments should be discontinued;
  • Photosensitivity disorder that can be exacerbated by laser or intense light;
  • Herpes simplex in the treatment area;
  • Use of medications, herbal supplements, perfumes or cosmetics that may affect sensitivity to light;
  • Poor wound healing;
  • Sunburns;
  • Unable or unlikely to refrain from artificial tanning, including the use of tanning booths, prior (at least a week) and during the course of the evaluation;
  • Prior skin treatment with laser or other devices on the same treated areas within the last six months prior to study enrollment or during the course of the study.

Treatment and study plan

LightSheer Duet HS handpiece

Device

The approach to be studied here relies on a cleared modality, the LightSheer Duet High Speed (HS) that uses 805 nm diode laser with vacuum (K053628).

Primary outcomes

  1. Number of subjects with Adverse Events

    Time frame: 1 year

    To evaluate the safety of hair removal using the LightSheer Duet HS 805 nm handpiece

  2. Hair count

    Time frame: 6 monts follow up

    To verify hair removal and permanent hair reduction using the LightSheer Duet HS 805 nm handpiece

Secondary outcomes

  1. Subject's comfort using VAS

    Time frame: Baseline, 4, 8, 12, 16 weeks;

    To evaluate subject's assessment of comfort associated with treatments

  2. Asses subject's perception of improvement and satisfaction

    Time frame: 8, 16 weeks following baseline; 3 and 6 monts follow up

    To evaluate subject's satisfaction with hair removal treatments and assessment of improvement using subject's questionnaire

Sponsors and collaborators

Lead sponsor

Lumenis Be Ltd.

Industry

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Feb 28, 2013
Registry last updated
Apr 29, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.